Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant?
| Data(s) |
2005
|
|---|---|
| Identificador | |
| Publicador |
Informa Healthcare |
| Relação |
DOI:10.1517/13543784.14.3.339 Doggrell, Sheila (2005) Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant? Expert Opinion on Investigational Drugs, 14(3), pp. 339-342. |
| Palavras-Chave | #060100 BIOCHEMISTRY AND CELL BIOLOGY #060500 MICROBIOLOGY #111500 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES #Alcoholism, CB1 Receptor Antagonist, CB1 Receptor, Obesity, Rimonabant, Sardinian Alcohol-Preferring Rats, SR-147778 |
| Tipo |
Journal Article |
